SCHEMBL22890488

SCHEMBL22890488

Cc1ncc(C#N)c2c1CCC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.42
ALDH1A1 P00352 3/20 0.40
TSHR P16473 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35
HTT P42858 1/20 0.35
MAPK1 P28482 1/20 0.34
CHRNB2 P17787 4/20 0.34
CHRNB4 P30926 4/20 0.34
CHRNA3 P32297 4/20 0.34
CHRNA4 P43681 4/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
CSNK1A1 P48729 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
POLB P06746 1/20 0.33
APEX1 P27695 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25020899 0.94 KDM4E (0.44) KDM4EALDH1A1TSHRCYP1A2CYP3A4
SCHEMBL28388786 0.78 BRD4 (0.38) KDM4EALDH1A1TSHRMAPK1CYP11B2
SCHEMBL18819887 0.78 KDM4E (0.34) KDM4EALDH1A1
SCHEMBL14988176 0.78 CSNK1A1 (0.40) KDM4EALDH1A1HTTMAPK1CYP11B2
SCHEMBL22890487 0.76 KDM4E (0.39) KDM4EALDH1A1TSHRCYP1A2CYP3A4
SCHEMBL29741000 0.76 TSHR (0.39) KDM4EALDH1A1TSHRHPGDMAPK1
SCHEMBL19009020 0.76 TSHR (0.39) KDM4EALDH1A1TSHRHPGDMAPK1
SCHEMBL30112211 0.74 LRRK2 (0.38) ALDH1A1LRRK2
SCHEMBL10037033 0.73 SMN1; SMN2 (0.43) KDM4EALDH1A1HTTMAPK1CYP11B2
SCHEMBL22889705 0.73 KDM4E (0.33) KDM4EALDH1A1HTTMAPK1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021007477-A1 INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS E-SCAPE BIO, INC. (US) 2021-01-14 WO disclosed